Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopropofol plus alfentanil vs propofol plus alfentanil in tumor interventional procedures
ChiCTR2500104450Phase 4Not yet recruiting
- Sponsor
- Lishui City Central Hospital
- Start
- Jun 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Nonhematologic neoplasms comparing Cyclopropofol + alfentanil with Propofol + alfentanil (2 arms). Primary endpoint: Incidence of respiratory system-related adverse events. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
ciprofolpropofolalfentanil
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on ChiCTR2500104450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104450.